Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.
about
Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine modelA matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironmentReduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients.Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection.Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical screening.
P2860
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeting myeloid-derived supp ...... activity against lung cancer.
@ast
Targeting myeloid-derived supp ...... activity against lung cancer.
@en
type
label
Targeting myeloid-derived supp ...... activity against lung cancer.
@ast
Targeting myeloid-derived supp ...... activity against lung cancer.
@en
prefLabel
Targeting myeloid-derived supp ...... activity against lung cancer.
@ast
Targeting myeloid-derived supp ...... activity against lung cancer.
@en
P2093
P2860
P356
P1476
Targeting myeloid-derived supp ...... activity against lung cancer.
@en
P2093
Maie St John
Marni Harris-White
Minu K Srivastava
Robert B Cameron
Robert Strieter
Sherven Sharma
Steven Dubinett
P2860
P356
10.2147/ITT.S32617
P50
P577
2012-10-01T00:00:00Z